摘要
人用动物免疫血清类制品(抗毒素、抗血清)已在临床使用多年,由于这类制品在临床治疗的不可替代性以及在反生物恐怖中的战略意义,近年来受到国内外更多的关注。本文对我国抗毒素、抗血清制品质量标准的发展和完善进行了探讨。
Animal immunoglobulin and immunosera for human use have been used in clinical therapy for many years. Because of their exclusive characteristic in treatment of some infectious diseases and strategic significance in anti-bioterrorism, more attention is now focused on these products. This article discussed on the development of the quality control of animal immunoglobulin and immunosera for human use in china.
出处
《中国药品标准》
CAS
2008年第1期19-23,共5页
Drug Standards of China